Cyrusbio
Founded 2014 · 6 known investors
Cyrus Bio is a computational drug discovery company that uses protein design, deep mutagenesis, and modeling algorithms to engineer naturally occurring proteins into therapeutics. Its pipeline targets severe autoimmune, gastrointestinal, metabolic, and respiratory conditions, including IgG-depletion and cytokine-based biologic candidates.
AI & Machine LearningBiotechDeep Tech
Investors · 6
Frequently asked questions
- What does Cyrusbio do?
- Cyrus Bio is a computational drug discovery company that uses protein design, deep mutagenesis, and modeling algorithms to engineer naturally occurring proteins into therapeutics. Its pipeline targets severe autoimmune, gastrointestinal, metabolic, and respiratory conditions, including IgG-depletion and cytokine-based biologic candidates.
- Who are Cyrusbio's investors?
- Cyrusbio's investors include Anzu Partners, Argonautic Ventures, iSelect Fund, OrbiMed, SPRINGROCK VENTURES, Agent Capital.